Enveda Biosciences Stock
A drug analysis platform that accelerates medicine creation using machine learning, metabolomics, and robotics to analyze natural samples for chemical structure, activity, and function—eliminating the need for isolating compounds or extensive testing. It helps healthcare clients develop antibiotics, hypotensives, and identify molecules from living organisms.
Founded: 2019
For more Enveda Biosciences stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Viswa Colluru, PhD Founder & Chief Executive Officer |
| August Allen Chief Technology Officer |
| Hannah Gordon, PhD Chief Product Officer |
